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~ Difficult classification and management of pulmonary 
aspergillosis (PA) in Cystic Fibrosis 
I. De Schutter 1 , E. De Wachter 1 , C. Ernst 2, A. Goossens 3, A. Malfroot 1. 1Dept. 
of Paediatrics, Respiratory Medicine and Inj~ctious Diseases', CF-clinic, 2Dept. of 
Radiology, 3Dept. of Pathology, Academic Hospital AZ-VUB Brussels, Belgium 
Introduction: Aspergillus fumigatus (Af) causes various pulmonary entities rang- 
ing from aspergilloma in lung cavities (1), allergic or hypersensitive r actions 
(ABPA) (2), chronic necrotizing aspergillosis n chronic lung disease (3) to invasive 
infection in immunocompromised hosts (4). ABPA is reported in 2 15% of adult 
CF patients, fulfilling 4 minimal criteria. 
Patients: In the past 6 months, we had 2 young CF patients, a 9 year old male and 
a 12 year old girl with PA, and overlapping criteria of entity 2 and 3. 
Results: the boy had normal ungfunction, total IgE 2330 KIU/1, and elevated Af- 
specific IgE and IgG, a large peripheral infiltrate, with eosinophilic granulomatous 
reaction and fungal hyphy on transthoracic needle biopsy (sputa were negative). 
The girl has an FEV1 60% (without asthma symptoms), normal IgE, hemoptysis 
and repeated positive sputum cultures for Af, being the only pathogen cultured, 
including bacteria nd also a large peripheral infiltrate. Both responded very well 
to voriconazole with disappearance of the infiltrates. Oral steroids given to the first 
patient resulted in steroid related iabetes. 
Conclusions: PA is also seen in young CF patients, ABPA criteria are not always 
fulfilled and clinical entities of PA overlap. Diagnosis may be difficult and the 
causal role of Af  in lung infiltrates is difficult to asses (needing biopsy in case 1). 
Treatment guidelines are not uniform and the use of oral steroids includes risk for 
important side-effects. 
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NEar ly  detection of exacerbation of allergic bronchopulmonary 
aspergillosis in Cystic Fibrosis by lung function testing 
D. Schtiler, C. Geidel, K. Weber, P Bittner-Dersch, H. Lindemann. CF Centre, 
University Hospital GiefJen and Marburg GmbH, Germany 
Aims: Allergic bronchopulmonary aspergillosis (ABPA) is reported in 15% of 
patients with cystic fibrosis (CF). The diagnose in an early stage without persistent 
alterations of bronchial wall and lung tissue is crucial for prognosis of ABPA. The 
question was whether an episode of the APBA can be promptly recognized and 
treated measuring the inspiratory vital capacity at home. 
Methods: In 143 CF patients (7 months to 38y.) the diagnosis of ABPA was 
examined and supplemented if necessary. The diagnosis ABPA was made if 
independently of an episode of infection an unexpected ventilation impairment 
was observed and a sensitization by proof of specific IgE (or rh Asp f2,4,6) and/or 
IgG in the serum against aspergillus fumigatus was detectable. In 6 ABPA-patients 
(10 23 y.) the inspiratory vital capacity (VCin) was daily determined with an handy 
spirometer (SpiroPro ®, Viasys, Germany). 
Results: In 70 (48 .9%)  of the 143 CF patients (6 weeks to 35y.) a sensitization 
to aspergillus fumigatus (specific serum IgE or IgG or combines) was found. In 
50 CF patients (6 33 y.) the above-mentioned criteria of the ABPA were fulfilled 
(34.9%).  In 20 of these ABPA patients (40%)  no picture-giving changes howed 
up. Within 6 months by means of monitoring VCin altogether 8 episodes with a 
reduction of the inspiratory vital capacity about 15% were observed in 6 ABPA 
patients. The exacerbations was reversible within a few days after early use of 
systemic orticosteroids in each case. 
Conclusions: The frequency of the ABPA in CF is substantially underestimated. 
In CF patients with ABPA regular measurements of the inspiratory vital capacity 
performed by the patient at home can contribute to early detection of an exacerbation 
and treatment. 
• Effect of broncho-pulmonary aspergillosis (ABPA) on 
progression of lung function in children with Cystic Fibrosis 
R. Kraemer 1 , N. Delosea 1 , P Ballinari 2, S. Gallati 1 . 1Department of Paediatrics, 
2Institute of Psychology, University of Berne, Switzerland 
The relationship between sensitization to A. fumigatus (sAf) and progression of 
pulmonary function is not yet established. We aimed to evaluated onset of sAf 
and development of ABPA, as well as to determine the physiological factors (pul- 
monary hyperinflation, ventilation inhomogeneities, bronchial obstruction) which 
dominantly influence these mechanisms in CE Serial annual ung function tests, 
performed in 122 CF-children (62 males; 60 females; age: 6 18 y), provided ata 
pertaining to functional residual capacity (FRCpleth), lung clearance index, volume 
of trapped gas, effective specific airway resistance (sRefi), and forced expiratory 
indices (FEV1, FEF50). IgE and recombinantA.fumigatus llergens rAspfl, rAspf3, 
rAspf4 and rAspf6 served as marker for sAl~ ABPA was diagnosed by Nelson 
criteria. By linear mixed model-effect analysis 5 subgroups of patients: (i) not 
sensitized and free from PA, (ii) intermittently PA-colonized, (iii) chronically PA- 
infected, (iv) Af-sensitized, and (v) ABPA were evaluated, sAf was best reflected 
by increased rAspfl_3, showing best positive predicting values. In most patients 
sAf was preceded by PA infection. ABPA patients demonstrated the most severe 
progression i all lung function parameters (p< 0.0001), and sAfwas best reflected 
by FEF50 and sReff (p < 0.001). Taking additionally into account PA-infection, 
discrimination between sAf and ABPA was best shown by FEF50, sRefl; and 
FRCpleth (p < 0.001). Thus, airway narrowing, small airway disease and pulmonary 
hyperinflation seem to be the major targets functional derangement in ABPA. 
Specific lung function parameters have to be taken as follow-up parameter, if the 
effect of sAf and ABPA development is aimed to be evaluated. 
• Prevalence of aspergillus/allergic bronchopulmonary 
aspergillosis in a CF population 
S.H. Chotirmall, P Branagan, A.M. Lyons, T.B. Low, N.G. McElvaney. Dept of 
Respiratory Medicine; Beaumont Hospital, Dublin, Ireland 
Introduction: CF patients can become colonized by Aspergillus. Acting as an 
allergen, a hypersensitivity reaction may result, leading to ABPA. This study aims 
to discover the prevalence of aspergillus colonisation and subsequent ABPA in our 
CF population. 
Methods: 50 CF patients were retrospectively analysed for presence of Aspergillus 
in their sputum. The presence, treatment and subsequent lung function (FEV1) at 
every episode of ABPA were recorded. ABPA was defined by presence of any one 
or more of the following: (i) acute/subacute clinical deterioration not attributable to
another aetiology; (ii) positive serum aspergillus precipitans; (iii) increased serum 
IgE >500IU/mL; (iv) aspergillus positive IgE RAST; (v) immediate cutaneous 
reactivity to Aspergillus; or (vi) new/recent abnormalities on chest radiography not 
cleared with antibiotics or physiotherapy. 
Results: 15 of 50 CF patients grew aspergillus pecies in their sputum culture 
(30.0%). 6 of 15 patients had ABPA (40.0%). All individuals with ABPA were 
treated with oral corticosteroids. One was given itraconazole. There was no 
difference in lung function (FEV1) in subjects with aspergillus positive sputum 
(mean value 50.2% in aspergillus group versus 67.5% predicted in a matched non- 
aspergillus group, p-value 0.09). Subjects with ABPA experienced sharp short-term 
deterioration i  lung function which returned to baseline following at least 4 weeks 
of treatment. 
Conclusions: Prevalence of ABPA was 12.0%. Aspergillus positive sputum was not 
a poor prognostic sign in terms of lung function however, the number studied was 
small. This contrasts previous reports of this group showing Aspergillus putum 
presence in CF being associated with more severe radiological abnormalities on 
HRCT thorax scanning. APBA produces hort-term reversible decline in lung 
function. Interestingly, frequency of isolates of aspergillus did not correlate with 
occurrence of ABPA. 
